These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25043013)

  • 1. Gene regulation: fine-tuned amplification in cells.
    Dang CV
    Nature; 2014 Jul; 511(7510):417-8. PubMed ID: 25043013
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.
    Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B
    Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles.
    Walz S; Lorenzin F; Morton J; Wiese KE; von Eyss B; Herold S; Rycak L; Dumay-Odelot H; Karim S; Bartkuhn M; Roels F; Wüstefeld T; Fischer M; Teichmann M; Zender L; Wei CL; Sansom O; Wolf E; Eilers M
    Nature; 2014 Jul; 511(7510):483-7. PubMed ID: 25043018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.
    Schneider C; Setty M; Holmes AB; Maute RL; Leslie CS; Mussolin L; Rosolen A; Dalla-Favera R; Basso K
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8185-90. PubMed ID: 24843176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIAS1 Promotes Lymphomagenesis through MYC Upregulation.
    Rabellino A; Melegari M; Tompkins VS; Chen W; Van Ness BG; Teruya-Feldstein J; Conacci-Sorrell M; Janz S; Scaglioni PP
    Cell Rep; 2016 Jun; 15(10):2266-2278. PubMed ID: 27239040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC, metabolism, cell growth, and tumorigenesis.
    Dang CV
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread microRNA repression by Myc contributes to tumorigenesis.
    Chang TC; Yu D; Lee YS; Wentzel EA; Arking DE; West KM; Dang CV; Thomas-Tikhonenko A; Mendell JT
    Nat Genet; 2008 Jan; 40(1):43-50. PubMed ID: 18066065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research advance on c-myc in aggressive B cell lymphomas].
    Zhou J; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):786-8. PubMed ID: 24447565
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer: An unexpected addiction.
    Shaughnessy JD
    Nature; 2008 Jul; 454(7201):172-3. PubMed ID: 18615074
    [No Abstract]   [Full Text] [Related]  

  • 10. Unlocking the mysterious mechanisms of Myc.
    Nat Med; 2013 Jan; 19(1):26-7. PubMed ID: 23296005
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncogene addiction: sometimes a temporary slavery.
    Jonkers J; Berns A
    Cancer Cell; 2004 Dec; 6(6):535-8. PubMed ID: 15607957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
    Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
    Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNK1 and JNK2 play redundant functions in Myc-induced B cell lymphoma formation.
    Anbalagan M; Sabapathy K
    Int J Cancer; 2012 Apr; 130(8):1967-9. PubMed ID: 21630260
    [No Abstract]   [Full Text] [Related]  

  • 14. Translocations involving c-myc and c-myc function.
    Boxer LM; Dang CV
    Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse Models of
    Ferrad M; Ghazzaui N; Issaoui H; Cook-Moreau J; Denizot Y
    Front Immunol; 2020; 11():1564. PubMed ID: 32793219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.
    Forshell LP; Li Y; Forshell TZ; Rudelius M; Nilsson L; Keller U; Nilsson J
    Oncotarget; 2011 Jun; 2(6):448-60. PubMed ID: 21646687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
    Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
    Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo Richter transformation.
    Chiecchio L; Cullis JO
    Blood; 2017 Apr; 129(17):2455. PubMed ID: 28450576
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcriptional regulation and transformation by Myc proteins.
    Adhikary S; Eilers M
    Nat Rev Mol Cell Biol; 2005 Aug; 6(8):635-45. PubMed ID: 16064138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.
    Hoellein A; Fallahi M; Schoeffmann S; Steidle S; Schaub FX; Rudelius M; Laitinen I; Nilsson L; Goga A; Peschel C; Nilsson JA; Cleveland JL; Keller U
    Blood; 2014 Sep; 124(13):2081-90. PubMed ID: 25143484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.